Johnson & Johnson to Participate in the 2025 Wells Fargo Healthcare ConferenceBusiness Wire • 07/24/25
Why Johnson & Johnson (JNJ) is a Top Momentum Stock for the Long-TermZacks Investment Research • 07/24/25
J&J Innovative Medicine Unit Shines Again in Q2: Will This Continue?Zacks Investment Research • 07/24/25
How To Build A $100,000 Dividend Portfolio: Targeting A Yield Of 15%+ In 20 YearsSeeking Alpha • 07/23/25
What Is Considered a Good Stock Dividend? 2 Healthcare Stocks That Fit the Bill.The Motley Fool • 07/23/25
Should J&J Stock Be in Your Portfolio After Q2 Beat & Guidance Raise?Zacks Investment Research • 07/21/25
Johnson & Johnson seeks first icotrokinra U.S. FDA approval aiming to revolutionize treatment paradigm for adults and adolescents with plaque psoriasisPRNewsWire • 07/21/25
J&J Expects Oncology Sales of USD 50B by 2030: Can It Achieve the Goal?Zacks Investment Research • 07/18/25
Johnson & Johnson receives U.S. FDA Priority Review for TAR-200 NDA in high-risk non-muscle invasive bladder cancerPRNewsWire • 07/17/25
Dow Futures flat amid latest Trump vs Powell fiasco: 5 things to know before Wall Street opens todayInvezz • 07/17/25